|
Public Health & Epidemiology
Monday, June 24, 2013 | 10:30 AM - 3:00 PM | The Ross Prize, established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine, is awarded to an investigator producing innovative, paradigm-shifting research worthy of significant attention in molecular medicine. More
This eBriefing investigates integrated interventions for early childhood development. It reviews methods, timing, measurement, scaling up, and other topics. More
A collection of four meeting reports on omics platforms in diabesity, prioritizing health disparities in medical education, the paradox of overnutrition, and vitamin D: beyond bone. More
-
Monday, June 24, 2013 | 10:30 AM - 3:00 PM
Speakers: Yasmine Belkaid (National Institute of Allergy and Infectious Diseases, NIH), Dan R. Littman (New York University School of Medicine), Alexander Rudensky (Memorial Sloan-Kettering Cancer Center)
The Ross Prize, established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine, is awarded to an investigator producing innovative, paradigm-shifting research worthy of significant attention in molecular medicine.
Wednesday, September 18, 2013 | 5:00 PM - 6:45 PM
Moderator: Orla M. Smith (Science Translational Medicine)
Panelists: Amanda Boxtel (Ekso Bionics), Grégoire Courtine (Swiss Federal Institute of Technology, EPFL), Nathan Harding (Ekso Bionics)
Join us for a discussion of cutting-edge technologies that may revolutionize spinal cord injury rehabilitation and treatment. Included in the discussion is a live demonstration of a wearable robot (or exoskeleton) that enables people with lower-extremity paralysis or weakness to stand and walk. We will present perspectives from an innovator, a researcher, and a patient, who will share their insights on how these new technologies benefit the public now and in the future to come.
June 19 - 20, 2013
Conference Planning Committee: Claudio Carini (Pfizer Inc.), Teresa Compton (Biogen Idec (Conference Chair)), Marion Kasaian (Pfizer Inc.), Theodora Salcedo (Bristol-Myers Squibb Company), Anne Vogt (F. Hoffmann-La Roche Ltd)
Scientific Advisory Board: Leonard Calabrese (Cleveland Clinic), Paola Cinque (Hospital San Raffaele), David Clifford (Washington University School of Medicine), Robert Garcea (University of Colorado at Boulder), Eugene Major (National Institute of Neurological Disorders and Stroke), Kenneth Tyler (University of Colorado Anschutz Medical Campus), Thomas Weber (University of Hamburg)
New basic science and clinical findings relevant to the pathogenesis, mitigation, cure, and risk stratification of Progressive Multifocal Leukoencephalopathy will support a discussion of current challenges and future directions for PML treatment.
Wednesday, June 12, 2013 | 7:45 AM - 6:00 PM
In-house event is SOLD OUT! Register for the live webinar.
Speakers: Martin J. Blaser (New York University School of Medicine), Sir Harry Burns (Scottish Government, Scotland), Patrice D. Cani (Université Catholique de Louvain, Belgium), Fred H. Degnan (King & Spalding LLP), Joël Doré (Institut National de la Recherche Agronomique, France), Jane A. Foster (McMaster University, Canada), Gary Frost (Imperial College London, United Kingdom), Patricia L. Hibberd (Harvard Medical School / Massachusetts General Hospital for Children), John Hutton (University of York, United Kingdom), Todd Klaenhammer (North Carolina State University), David A. Mills (University of California, Davis), Max Nieuwdorp (University of Amsterdam, The Netherlands), Bruno Pot (Institut Pasteur de Lille, France), Rowena Pullan (Pfizer Consumer Healthcare), Helen E. Raybould (University of California, Davis), Gregor Reid (Western University / Lawson Health Research Institute, Canada), David A. Relman (Stanford University School of Medicine), Andrew Serazin (Matatu LLC)
Explore research and policy strategies to translate scientific knowledge on the convergence of the microbiome, prebiotics, probiotics, and host physiology into nutritional and therapeutic applications for inflammation, obesity, diabetes, gastrointestinal disease, and malnutrition.
Thursday, June 6, 2013 | 8:30 AM - 6:30 PM
Organizers: Sharon R Akabas (Columbia University), Gerald Friedman (The Icahn School of Medicine at Mount Sinai), Martin Kohlmeier (University of North Carolina at Chapel Hill), Charlotte Pratt (National Institutes of Health), Gwen Twillman (American Society for Nutrition), Mandana Arabi (The Sackler Institute for Nutrition Science), Brooke Grindlinger (The New York Academy of Sciences)
This conference aims to revisit the current nutrition curricula for health professionals and to explore how trainings can better provide the skills necessary for implementing the array of preventative and therapeutic nutrition interventions available. Presented as part of the Translational Medicine Initiative.
Thursday, May 30, 2013 | 9:00 AM - 5:00 PM
Review progress on key aspects of the Plasmodium vivax research agenda as they pertain to malaria treatment, control, and elimination through a series of free, interdisciplinary workshops.
|
-
eBriefing
Organizers: Maureen M. Black (University of Maryland), Kathryn G. Dewey (University of California, Davis), Lia Fernald (University of California, Berkeley), Sally Grantham-McGregor (University College London, UK), Theodore D. Wachs (Purdue University), Susan Walker (University of the West Indies, Jamaica), Aisha K. Yousafzai (Aga Khan University, Pakistan), and Mandana Arabi (The Sackler Institute for Nutrition Science)
This eBriefing investigates integrated interventions for early childhood development. It reviews methods, timing, measurement, scaling up, and other topics.
Annals
Edited by Annals of the New York Academy of Sciences editorial staff
A collection of four meeting reports on omics platforms in diabesity, prioritizing health disparities in medical education, the paradox of overnutrition, and vitamin D: beyond bone.
eBriefing
Organizers: Johanne Morne (New York State Department of Health AIDS Institute), Sonja Noring (New York State Department of Health AIDS Institute), Cheryl Smith (New York State Department of Health AIDS Institute), AIDS Institute Social Media Workgroup (New York State Department of Health AIDS Institute), Brooke Grindlinger (The New York Academy of Sciences), and Kerstin Hofmeyer (The New York Academy of Sciences)
This eBriefing looks at the impact of digital technologies on clinical care, especially for HIV and other sexually transmitted infections, exploring eHealth strategies for patient-centered care and clinical decision support.
eBriefing
Moderator: Tom Vanderbilt (Author)
Panelists: Mariela Alfonzo (Polytechnic Institute at New York University), Kaid Benfield (Natural Resources Defense Council), and Hunter Reed (FAST NYC)
As part of the Academy's Science and the Seven Deadly Sins series, a panel discussed urban design in NYC and explored how the built environment affects public health.
Good oral hygiene helps prevent tooth decay and gum disease, but the health of your mouth may have a big impact on the rest of your body too—especially if you have diabetes.
Delve into the world of prebiotic and probiotic science. We talk to three people in the field and learn why keeping the good microbes in our bodies happy means a lot for health.
Podcast
February 26, 2010
NYU's food guru Marion Nestle gives you a lesson in decoding food labels, holding big food corporations accountable, and choosing food wisely. She spoke as part of S&C's Girls Night Out series.
We talk to two scientists at Hunter College who research different aspects of Autism Spectrum Disorder(ASD). Jason Dictenberg studies synapses in our brain, and Michael Siller looks at play-based therapies for autistic children. Both are on the cutting edge of new research in the field of autism.
Webinar Archive
March 2, 2010
Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.
Translational Medicine Initiative
 The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.
|
|
|